NTOL Natrol (MM)

Natrol, Inc. (NASDAQ:NTOL), a premier manufacturer and distributor of nationally branded nutritional products, today announced that current Director Thomas Doorley was elected Lead Director during the Company's Board of Directors meeting on September 15, 2006. Mr. Doorley has been an independent member of the Natrol Board since February 2006. "Adding further structure to the Natrol Board will help our company's compliance and decision making process. Tom Doorley is a leading corporate strategist with a view to higher performance," said Wayne Bos, President and CEO of Natrol. About Natrol Founded in 1980, Natrol, Inc. (NASDAQ:NTOL) is a diversified nutrition company that manufactures and distributes premium branded nutritional supplements, herbal teas and sports nutrition products under the Natrol(R), Laci Le Beau(R) and Prolab(R) brands, respectively. Natrol markets approximately 50 categories of products with more than 500 stock-keeping units (SKUs) designed to meet a wide range of consumer needs. The products are available at thousands of food, drug, mass market and independent health food stores, catalogs and Internet sites, gyms and specialty stores nationally and in select foreign countries. For more information, visit www.natrol.com. The statements made in this press release which are not historical facts including statements regarding expectations for future growth of revenue and profits and trends concerning net sales, are forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. As a result of a number of factors, the Company's actual results could differ materially from those set forth in the forward looking statements. Certain factors that might cause Natrol's actual results to differ materially from those set forth in the forward looking statements include adverse trends in the dietary supplements industry, intense competition, adverse effects of unfavorable publicity regarding particular products or the Company's industry generally, the Company's dependence on the introduction of successful new products, the Company's ability to gain market share and shelf space in each of its distribution channels, the Company experiencing high rates of product returns, and adverse government regulation, as well as those factors set forth under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2005 and in the Company's other filings with Securities and Exchange Commission. Natrol, Inc. (NASDAQ:NTOL), a premier manufacturer and distributor of nationally branded nutritional products, today announced that current Director Thomas Doorley was elected Lead Director during the Company's Board of Directors meeting on September 15, 2006. Mr. Doorley has been an independent member of the Natrol Board since February 2006. "Adding further structure to the Natrol Board will help our company's compliance and decision making process. Tom Doorley is a leading corporate strategist with a view to higher performance," said Wayne Bos, President and CEO of Natrol. About Natrol Founded in 1980, Natrol, Inc. (NASDAQ:NTOL) is a diversified nutrition company that manufactures and distributes premium branded nutritional supplements, herbal teas and sports nutrition products under the Natrol(R), Laci Le Beau(R) and Prolab(R) brands, respectively. Natrol markets approximately 50 categories of products with more than 500 stock-keeping units (SKUs) designed to meet a wide range of consumer needs. The products are available at thousands of food, drug, mass market and independent health food stores, catalogs and Internet sites, gyms and specialty stores nationally and in select foreign countries. For more information, visit www.natrol.com. The statements made in this press release which are not historical facts including statements regarding expectations for future growth of revenue and profits and trends concerning net sales, are forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. As a result of a number of factors, the Company's actual results could differ materially from those set forth in the forward looking statements. Certain factors that might cause Natrol's actual results to differ materially from those set forth in the forward looking statements include adverse trends in the dietary supplements industry, intense competition, adverse effects of unfavorable publicity regarding particular products or the Company's industry generally, the Company's dependence on the introduction of successful new products, the Company's ability to gain market share and shelf space in each of its distribution channels, the Company experiencing high rates of product returns, and adverse government regulation, as well as those factors set forth under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2005 and in the Company's other filings with Securities and Exchange Commission.